Skip to main content

Looking Deep into Cells for the Answers to Parkinson's

May 16, 2019

Our panelists discuss efforts to better understand what goes wrong in Parkinson's on the deepest level -- in the genes and proteins that are the instructions and ingredients for life. Researchers discuss how defining these differences can point to better ways to measure and treat Parkinson's disease.

Webinar Details


Thursday, May 16, 2019


1 hr


12:00 pm ET
  • Continuing Medical Education Information for Health Care Professionals

    MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursdays Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: May 16, 2019
    Date CME Credit No Longer Available: May 16, 2021 

    Learning Objectives
    At the conclusion of this course, participants should be able to:

    1. Describe the roles of cellular DNA, RNA and proteins.
    2. Understand how scientists sequence DNA, RNA and proteins and how they analyze that data to look for differences between people with and without Parkinson’s.
    3. Summarize how finding differences in DNA, RNA and proteins in people with Parkinson’s may help better define, measure and treat the disease.
    4. Discuss how robust data sets, such as from the Parkinson’s Progression Markers Initiative (PPMI), can help understand the connection between changes in DNA, RNA and proteins and the clinical experience of disease.

    Target Audience
    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing and The Michael J. Fox Foundation for Parkinson's Research. Oakstone Publishing is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Oakstone Publishing has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing's planners, content reviewers, and editorial staff disclose no relevant commercial interests.


    Maggie Kuhl​
    Research Communications, ​The Michael J. Fox Foundation
    Nothing to disclose

    Bradford Casey, PhD​
    Research Programs, ​The Michael J. Fox Foundation
    Nothing to disclose

    David Craig, PhD​
    Co-Director, Institute ​of Translational Genomics, ​University of Southern California​
    Nothing to disclose

    Samantha Hutten, PhD​
    Research Partnerships, The Michael J. Fox Foundation​
    Nothing to disclose

    Kendall van Keuren-Jensen, PhD​
    Professor of Neurogenomics, Translational Genomics Research Institute 
    Nothing to disclose

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.